Louisiana 2025 Regular Session

Louisiana Senate Bill SB26

Introduced
3/28/25  
Refer
3/28/25  
Refer
4/14/25  
Report Pass
4/16/25  
Engrossed
4/23/25  
Refer
4/24/25  
Report Pass
5/20/25  
Enrolled
6/12/25  
Chaptered
6/20/25  

Caption

Provides relative to diabetes information. (8/1/25) (EN NO IMPACT See Note)

Summary

SB 26 requires the Louisiana Department of Health to develop informational materials about type 1 diabetes and provide them to the state Department of Education. The Department of Education must then distribute those materials to city, parish, and other local public school boards. The required materials must explain what type 1 diabetes is, identify its risk factors and warning signs, and describe the need for screening students for early detection using a blood autoantibody test. The bill also directs the materials to advise parents or guardians that if a student shows warning signs or receives positive early screening results, they should promptly consult the student’s primary care provider to develop a treatment plan. That plan may include referral to a specialty care provider, including an endocrinologist. Local school boards must provide the information to parents and legal guardians of all prekindergarten, elementary, and secondary students at enrollment and annually thereafter, either by posting it on school websites or by electronic distribution.

Impact

SB 26 adds R.S. 17:436.3.1 to Louisiana law and creates a new school-health information distribution requirement. It does not mandate medical screening by schools or change student eligibility rules, but it does require state agencies and local school boards to circulate standardized type 1 diabetes information to families. The practical effect is to embed diabetes awareness and early-detection guidance into routine school communications for public school students statewide.

Sentiment

The bill appears to have been broadly supported and noncontroversial. It passed the Senate and House with unanimous or near-unanimous votes, and the available voting history shows no recorded opposition at any stage. The caption also notes “EN NO IMPACT,” suggesting the measure was viewed as a limited, informational policy rather than a costly or regulatory change.

Contention

There is little evidence of substantive contention in the available record. The main policy choice reflected in the bill is whether schools should be required to distribute health information about type 1 diabetes and early screening; the unanimous votes suggest broad agreement on that approach. Any potential concern would likely center on the inclusion of screening language and whether school communications could be seen as encouraging medical testing, but no recorded debate or opposition is provided in the materials.

Companion Bills

No companion bills found.

Similar Bills

No similar bills found.